Medical Device Company Drops over 40% Today

A downgrade to its fiscal year's sales forecast proved unsettling.                                                                                                                                                                                                                                                                                                                                                                                                                 July 26, 2024 | [Read Online]( Medical Device Company Drops over 40% Today A downgrade to its fiscal year's sales forecast proved unsettling. [fb]( [fb]( [fb]( [fb](mailto:?subject=Post%20from%20Elite%20Trade%20Club&body=Medical%20Device%20Company%20Drops%20over%2040%25%20Today%3A%20A%20downgrade%20to%20its%20fiscal%20year%27s%20sales%20forecast%20proved%20unsettling.%0A%0Ahttps%3A%2F%2Felitetrade.club%2Fp%2Fmedical-device-company-drops-40-today) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today. Markets 📈 The market continued its hot streak on Friday, with solid gains for U.S. indexes. The Russell 2K grew the most, but it was the Dow Jones that set a new record high. - DJIA [+1.64%] - S&P 500 [+1.11%] - Nasdaq [+1.03%] - Russell 2K [+1.72%] [Free Report: Five Top Cheap Stocks Poised for a Big Move]( Some of the greatest opportunities can be found in undervalued stocks. Often, a stock will become undervalued because of negative events, like the pandemic. Perhaps the company missed earnings, became overlooked, or was hit with downgrades. Or, maybe the stock fell along with its competition. Here are five of the most exciting, cheap stocks you may want to take a look at today. [Download Free Report]( » Want an Ad-Free Experience + Top Growth Stock Picks?[Upgrade Now!]( Market-Moving News 📈 Palantir's AI Platform Drives Significant Growth in U.S. Commercial Sector for 2024 🌟 Palantir's Remarkable Journey Palantir has been on a remarkable journey since its public offering in September 2020, consistently emphasizing the growth potential in the commercial sector. As we move through 2024, Palantir’s expansion in the U.S. commercial market, fueled by its Artificial Intelligence Platform (AIP), is showing significant momentum. This platform empowers customers by leveraging advanced AI and machine learning tools, integrated within Palantir's Foundry and Gotham systems. 📈 Impressive Q1 Growth In the first quarter of 2024, Palantir’s AIP continued to drive impressive growth. The U.S. commercial revenue surged by 40% year-over-year, reaching $150 million. Despite a slight deceleration from the previous quarter's 70% growth, the sequential acceleration highlights the robustness of this segment. 🏢 Focus on the Commercial Sector Palantir's commercial sector remains a key focus for investors, with AIP at the forefront. The company added 41 new U.S. commercial customers in Q1, a 69% year-over-year increase. This growth extended beyond the U.S., with the total commercial customer count rising to 427, marking a 53% year-over-year increase. 🚀 High Demand for AIP The ongoing interest in AIP is evident, with Palantir conducting over 915 bootcamps to meet the high demand. These bootcamps have proven effective in converting participants into paying customers and expanding existing contracts. In Q1, U.S. commercial deals increased by 94% year-over-year to 136, with the total contract value rising by 131% to $286 million. Overall, commercial bookings soared by 187% year-over-year to $505 million, with the U.S. contributing more than half. 💼 Rapid Deal Closures Palantir's ability to quickly close deals is another positive sign. For instance, a leading utility company signed a seven-figure deal just five days after completing a bootcamp. Such rapid deal cycles demonstrate the compelling value proposition of Palantir’s AIP. Top Winners and Losers 🔥 Windtree Therapeutics [WINT] $7.68 (+133.44%) Windtree Therapeutics doubled and then some today after a positive clinical trial update. Coursera [COUR] $10.73 (+44.85%) Coursera experienced a turnaround today after a favorable Q2 earnings report. 3M [MMM] $126.74 (+22.58%) 3M is up significantly after the company beat expectations for operating profit, EPS, and revenue in its Q2 earnings report. NovaBay Pharmaceuticals [NBY] $0.74 (-61.88%) NovaBay Pharmaceuticals dropped XX% today after announcing prices for 3,200,380 shares of common stock for its public offering. DexCom [DXCM] $63.83 (-40.81%) DexCom plummeted after downgrading this year’s sales forecast. Predictive Oncology [POAI] $1.39 (-25.60%) Predictive Oncology lost nearly all of yesterday’s gains after announcing an exercise of warrants to the tune of $1.26 million. That's it for today! Please write us back and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback! Thanks for reading. I'll see you at the next open! Best Regards, — Adam G. Elite Trade Club Text ELITESTOCKS to 47121 or [click here]( to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign Up for Mobile Alerts Now]( [Privacy Policy]( | [Advertiser Disclosure]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America [[beehiiv logo]Powered by beehiiv]( [Terms of Service](